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A B S T R A C T 
Nitric Oxide (NO) is color less, readily diffusible, highly reactive lipophilic and chemically unstable Free radical 
gas. NO is formed form arginine by enzyme nitric Oxide synthase. No acts in a paracrine or even autocrine manner. 
It causes asodilatation, act as neurotransmitter, Prevent Platelet aggregation and also play important role in macro- 
phase function. Deficiency leads to, increase vascular tone, reduced thrombolitic activity. Use of NO in pediatric 
pulmonary hypertension and in sexual dysfunction is increases day by day. The discovery  of NO  as an essential  
effectors  of many Biological  phenomenon  surely stand out as one of most important achievement of 20
th century 
of Biomedical investigation. 
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Introduction  
Nitric  Oxide  is  color  less,  readily  diffusible,  highly 
reactive lipophilic and chemically unstable Free radical 
gas. It is simple, hetrodiatomic molecule with broad and 
diverse effect on human biology by acting as Mediator 
in much reaction. NO
' is produced by many cell type, 
and  causes  vasodilatation,  act  as  neurotransmitter, 
Prevent  Platelet  aggregation  and  also  play  important 
role in macro- phase function
1.  
Nitrite  (NO2  –)  and  nitrate  (NO3  –)  are  known 
predominantly as undesired residues in the food chain 
with  potentially  carcinogenic  effects
2,3  or  as  inert 
oxidative end products of endogenous nitric oxide (NO) 
metabolism.  However,  from  research  performed  over 
the  past  decade,  it  is  now  apparent  that  nitrate  and 
nitrite are physiologically recycled in blood and tissues 
to form NO and other bioactive nitrogen oxides 
4-7. 
Lauder  Branton  is  the  person  to  use  nitric  oxide  as 
therapeutic agent for treatment of angina pectoris in the 
form of nitroglycerin and amyl nitrites. In 1977 Ferid 
Marad  showed  that  the  vasodilator  effect  of 
nitroglycerine is due to release of NO. In 1980 Robert 
furchgett showed that endothelium derived   relaxing 
factor  is      required  for  arteriolar  dilatation.  In  1987 
Louis Ignalro showed that Endothelium Derived growth 
Factor  is  chemically  NO.  For  above  work  they  got 
noble prize in 1998 
8-9.   
Nitrite  reduction    to  NO  and  NO  modified  proteins 
during physiological and pathological  hypoxia appear 
to  contribute  to  physiological  hypoxic  signaling, 
vasodilatation,  modulation  of  cellular  respiration  and 
the cellular response to Ischemic stress
7,  10,  11–16. This 
article reviews the metabolism and biological roles of 
NO within the body and its potential therapeutic use. 
Chemistry: Nitrite is unique to the nitrogen oxides in 
its redox position between oxidative (NO2 radical) and 
reductive  (NO  radical)  signaling  and  its  relative 
stability in blood and tissue
17. Once nitrite is formed, 
there are numerous pathways in the body for its further 
reduction to NO, involving haemoglobin
7, 18, myoglobin 
18,  19,  xanthine  oxidoreductase
20-22,  ascorbate16, 
polyphenols 
23, 24 and protons 
4, 5 
Nitric  Oxide  is  an  uncharged  molecule  having  an 
unpaired electron, so it is highly reactive free radical. 
So  It  is  correctly  written  with  superscript  dot  NO  =  
NO*.Being lipid soluble it can freely diffuse across the 
membrane.  Half-  life  is  very  short,  only  about  0.1  
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second, than it will   convert by Oxygen and water into 
nitrate and nitrites. 
Synthesis: Reduction of nitrite to NO occurs in blood 
and tissues and proceeds through several enzymatic and 
non-enzymatic  pathways.    The  acidic  reduction  of 
nitrite results in the generation of NO.  
In  1994,  two  groups  independently  described 
intragastric  NO  generation  from  salivary  nitrite  in 
humans 
4, 5. This process does not require NOS activity, 
but instead involves  the entero-salivary circulation of 
inorganic nitrate. Dietary nitrate is rapidly absorbed in 
the upper gastrointestinal tract. In the blood, it mixes 
with  the  nitrate  formed  from  the  oxidation  of 
endogenous  NO  produced  by  NOS  enzymes  form 
arginine. 
NOS is dimeric protein; it contains Heme, FAD, and 
FAM Calmodulin molecule tetrohydro Biopterin. 
BH4:  TetrahydroBiopterin  co  –  factor  required  for 
overall reaction. It is factor by which oxygenation of 
NO or Citruline take place. 
Heme:  Iron  Protoporphyrine  is  functional  prosthetic 
group associated with all three isoform of nitric oxide 
synthase  and  important  for  interaction  Between 
Flavoprotein and Heme Protein. 
4-aminoacid  motifs:  Glycine  –  lucine,  Glycine- 
Phenylanalin. Function is not clear but 
may   serve to target protein to specify site in cell. 
NADPH: Electrone donor. 
FAD, FMN: Use for flow of electrone 
Calmoduline:  a  14  KDa      Ca
+2  Binding  protein  is 
involved  in  the  control  of  electrone  flow.  Between 
prosthetic group in oxygenase molecule. 
There are three isoform of Nitric Oxide synthese. 
NOS I or n NOS or Neuronal NOS: it is Seen in central 
and  peripheral  nerve,  in  cerebellum  and  Gastro 
Intestinal tract. It is Mainly Cytoplasmic enzyme and 
Gene located on chromosome 12. If knocked out in the 
rat  result  in  the  vascular  stroke,  aggressive  sexual 
behavior in the male rate 
NOS  II  or  i  NOS  or  inducible  NOS:  Present  in 
monocytes,  macrophage,  smooth  muscle  cells 
microtubule,  endothelial  cells,  fibroblast 
cardiomyocyte,  hepatocytes  and  megakeryocite.  It  is 
induced by cytokine (IC – 1) during inflammation. It is 
also  Cytoplasmic  enzyme  but  Gene  located  on 
Chromosome:  17 and If knocked out, more susceptible 
to certain type of infection. 
NOS  3      or      e  NOS  or  endothelial  NOS:  Seen  in 
endothelial cells Platelet, endocardium and myocardium 
and at plasma membrane. Gene for this type of NOS is 
located on Chromosome 7 and If knocked out, result in 
increase blood pressure. 
There are two parallel pathways for the generation of 
bioactive  NO  in  mammals.  NO  is  a  key  signaling 
molecule  that  serves  to  regulate  a  wide  range  of 
physiological functions. It is classically produced from 
l‑arginine and oxygen by a family of enzymes, the NO 
synthase  (NOSs).  In  other  pathway,  the  inorganic 
anions nitrate and nitrite are reduced to form bioactive 
NO in blood and tissues during physiological hypoxia.  
Although NO generation by NOS becomes limited as 
oxygen  levels  fall,  the  nitrate–nitrite–NO  pathway  is 
enhanced.  By  the  parallel  action  of  both  of  these 
pathways, sufficient NO generation is ensured along the 
physiological  and  pathological  oxygen  and  proton 
gradients. 
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Sequence of event during NO synthesis is as Follow:  
Enzyme utilize   NADPH and molecule of O2   > From 
molecular oxygen, one is added to NO and other into 
Citruline  >  The  qunidionitrogen  of  arginine  is 
incorporated into NO > NADPH donates two electrone 
to FAD  which in tern reduce to FMN >  Flavin than 
reduced the   heme iron prosthetic group Fe
+2 to which 
oxygen    can  now  bind  for  the  oxygenation  of  the 
substrate L – arginine. 
Enzyme  activity  is  totally  depend  on  bound 
calmoduline which realize high      concentration  of 
Ca
+2 for N and E isoform of NOS.The reaction is totally 
inhibited by carbon monoxide. 
This  rate  of  NO  formation  increases  as  hemoglobin 
oxygen  saturation  decreases,  suggests  a  hypoxia-
regulated  mechanism  of  nitrite  bioactivation.  These 
chemical  properties,  and  supporting  physiological 
studies,  suggest  that  hemoglobin  may  function  as  an 
allosterically  regulated  nitrite  reductase  that  may 
contribute  to  hypoxic  signaling  and  hypoxic 
vasodilation
7,11,25,26. Interestingly, recent studies suggest 
that NO formed from nitrite reduction (equation 1) can 
react  with  a  second  nitrite  that  is  bound  to 
methaemoglobin (HbFe3+)
 27.  
The formation of bioactive nitric oxide (NO) from the 
inorganic  anion  nitrite  is  generally  enhanced  under 
acidic  and  reducing  conditions.  In  the  acidic  gastric 
lumen, NO is generated non-enzymatically from nitrite 
in saliva after  formation of  nitrous acid  (HNO2) and 
then decomposition into NO and other reactive nitrogen 
oxides. This NO helps to kill pathogenic bacteria and it 
also  stimulates  mucosal  blood  flow  and  mucus 
generation, thereby enhancing gastric protection.  
Mechanism Of Action: No acts in a paracrine or even 
autocrine manner. Signaling function of No begin with 
its  binding  to  protein  receptor  on  or  in  the  cell.  The 
binding site can be either A normal iron in the protein 
or One of its S atomic e.g. cysteine 
In  either  case  binding  trigger  an  allosteric  change  in 
protein, which in turn triggers the formation of a second 
messenger  within  the  cell.  Most  common  target  is 
Guanylyl Cyclase 
 
 Antagonist and inhibitors of NOS: N mono –methyl arginine competitively inhibit it so NOs used in septic shock 
to  Prevent  Hypo  tension.    Asymmetric  dimethyl 
arginine an endogenous analogue acts as NOS inhibiter 
which  is  increased  in  homocystenemia      only  pre  - 
eclampsia which isone of the factor leads to decrease 
NO  production  which  leads  to  Hypertension  during 
Eclempsia.  
Glucocorticoids  also  inhibit  NOS  transcription  which 
may  be  account  for  part  of  their  protective  effect  is 
septic  shock  syndrome.  In  case  of  loss  of 
Bioavailability  treatment  is  Dilatory  supplementation 
with   L arginine anti oxidant therapy which improved 
the  functional  deficit  of  NO.  Arginine  is  present  in  
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relatively  Large  amount  in  nuts  (Brazil  nuts  and 
almonds), Shell fish, Meats including Beef. 
Metabolic fate of NO: NO combine with O2 to Form 
NO2  These  nitrites  are  excreted  through  urine.  No 
combine with hemoglobin   it is converted to NO3 and 
nitrites, excreted in urine. Very low amount is expelled 
via lung. On exposure to super oxide anion   (O2  -) 
nitric oxide is converted to highly reactive free radical. 
Proxy nitrite (OONO) which cause lipid par oxidation, 
cell injury and cell death. Thus  as a free radical , NO 
readily undergo addition, substitution  redox and  chain 
terminating reaction which serve as molecular basis of  
its biological  effect. 
Measurement of NO: NO synthase requires   NADPH 
and it is   NADPH diaphoreses for which histochemical 
stain has been   available. Thus, it is easy to stain   for 
NO  synthese  in  Brain  and  other  tissue.  The  level  of 
metabolic product (nitrines, nitrate, 3 nitro tyrosine  in 
blood and urine are marker of NO production. 
Physiological Action Of Nitric Oxide 
On  Blood  vessels
9:  No  is  potent  vasodilator.  The 
normal  pressure  is  maintained  by  No  liberated  by 
endothelial  NOS.  It  is  observed  that  when  various 
derivative  of  Arginine  that  inhibit  No  synthesis  are 
administered  to  experimental  animal  there  is  prompt 
rise in Blood pressure which suggest that tonic release 
of NO is necessary to maintain normal blood pressure.  
At each systole, the endothelial cells that line the blood 
vessels  release  a  puff  of  NO.  This  diffuses  into  the 
underlying smooth muscles cells causing them to Relax. 
And  thus  permit  the  surge  of  blood  to  pass  through 
easily. Mice whose genus for the No synthese found in 
endothelial cell (eNOS) has been “knocked out “suffer 
from hypertension. 
Mechanical shares stress on vessel wall the important 
stimuli  to  induce  No  Synthesis.  No  causes  cerebral, 
coronary, renal and muscle arteries to dilate. nNOS  in 
neuronal  and  glial  cells  contributes    to  regulation  of 
cerebrovasculer tone  also help in memory and learning  
through    its  involvement  in  long  term  potentation  in 
central nervous system. 
Vasodilator action of NO is proved by various studies 
i.e.  humans  breathing  NO  gas  exhibit  increases  in 
peripheral forearm blood flow that  is associated  with 
increases  in  plasma  nitrite59,  suggesting  that  nitrite 
could be a stable endocrine  carrier and transducer of 
NO‑like  bioactivity  within  the  circulation60.  More 
recent  dose-response  experiments  in  normal  human 
volunteers reveal significant vasodilation of the forearm 
circulation  already  at  concentrations  as  low  as  300 
nM61 and a significant decrease in blood pressure after 
nitrate ingestion, associated with an increase in plasma 
nitrite levels from 140–220 nM62. 
On Platelet: Basal production of No by eNOS inhibit 
both  adhesion  and  aggregation  of  platelet  in 
vasculatures.   
On intestinal smooth muscle: NO is no adrenergic and   
non  –  cholinergic  neurotransmitter  especially  in  GIT 
and  urinary  tract.  No  relaxes  gastrointestinal  smooth 
muscle  and  leads  to  reduced  mobility,  relaxation  of 
sphincter  of  odd,  and  relaxation  of  lower  esophageal 
sphincter. A deficiency of NO producing neuron with 
decreased  mobility  is  responsible  for  infantile 
hypertrophic  pyloric  stenosis  and  HIRSPRUNG 
DISEASE.  Another  proposed  physiological  role  for 
gastric NO is in the regulation of mucosal blood flow 
and  mucus  generation
28  A  role  for  salivary  nitrite  in 
regulating  gastric  gastrin  release  has  also  been 
suggested
29 
On Bronchial smooth muscle: endogenously produced 
NO  may  contribute  to  maintenance  of  Basal,  Basal 
Bronchial and basal Pulmonary arterial wall tone. 
Role in Reproductive system
30: In Penile erection: The 
erection of penis during sexual excitation is mediated 
by No. Released from   nerve ending close the blood 
vessels  of  Penis,  Relaxation  of  these  muscle  cause 
blood to pool in blood sinuses producing an erection 
Role in fertilization:   The  acrosome  at  the  tip  of   
sperm head activates its NOS when it enters the egg. 
The resulting release of No in egg leads to (i) blocking   
the  entry  of  additional  sperm  and  (ii)  orienting 
pronucles for fusion. 
Role  in  Pregnancy:  NO  inhibit  uterine  muscle 
contraction during pregnancy. Also help in   cervical 
Ripening. 
Role in endocrine system: Stimulate   GnRh secretion 
from  Hypothelemus,      exocrine  pancreas  secretion 
adrenaline from Adrenal medulla.  
Role in Kidney:  NO increases tubular blood flow and 
which leads to increases GFR and second mechanism 
for increase in GFR is by inhibition of NO. 
NO and immunity: Production of NO by   i NOS in 
macrophages,  lymphocyte  and  neutrophil  is  an 
important determinant of   immune and inflammatory 
response. NO is hence play role in secretary immunity. 
No help in non specific immunity mile with “knocked  
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out  “gene  for  NO  suffer  from  severe  infections 
diseases. 
While  the  scientific  community  had  focused  on  the 
potentially  harmful  effects  of  nitrate  and  nitrite1,  the 
well-known antibacterial effects of NO 
31-34 suggested a 
role  for  gastric  NO  in  host  defense 
4,  5  interestingly; 
enteropathogens  can  survive  for  a  surprisingly  long 
time  in  acid  alone,  but  the  combination  of  acid  and 
nitrite  results  in  effective  killing  4.  NO  and  other 
reactive  nitrogen oxides  formed from acidified nitrite 
act  on  multiple  bacterial  targets  including  DNA, 
proteins and components of the cell wall 
38,47. 
NO  and  nervous  system:  NO  and  ANS:    Non 
cholinergic / Non adrenergic transmitter.  e.g.  in penis 
and  Intestine.  NO  and    medulla      Oblongata  :  O2 
deficiency  activate,  NO sensitive cell  which in  tern 
activate  respiratory    center  which  increases  rate  and 
depth  of  Breadth  NO  and    cerebral  center  :  Highly 
diffusible  so magnifies  localize  action  and help in 
memory and long term   potentiation. 
Pathological Effect 
Deficiency of NO   : It is associated with Hypertension 
as illustrated by recent observation in marine model of 
NOS3, in which gone inactivation done by homologues 
recombination.  Deficiency  represents  either  a  true 
deficiency of molecule or inactivation of it by reactive 
oxygen derived free radical. This deficiency leads to 
  increase vascular tone 
  reduced antithrombolitic activity 
  increase endothelial prolipheretive activity 
  increase endothelial permeability 
  enhance  susceptibility  to  low-density 
lipoprotein to oxidation. 
Deng  and  Rapp  have  demonstrated  a  clear  linkage 
Between  the  NOS2  gene  locus  and  self  sensitive 
hypertension in Dahl S rat. In chronic renal failure: The 
concentration  of  dimethyl  arginine,  a  naturally 
occurring derivative of L - Arginine is increased and 
competitively  inhibit  nitric  oxide  syntheses  activity, 
possible contributing to hypertension of chronic renal 
failure. 
In  Bacterial  sepsis  induction  of  NOS2  occur  and  the 
elaboration of NO in this setting accounts for the hypo 
tension  and  septic  shock  state  and  contribute  to  the  
hemodiathesis  of  sepsis  by  profoundly  inhibiting 
platelet  function.  The  myocardial  depression  
associated with septic  shock may be explained  in part 
by the  inhibition of myocardial contractility by NO. 
Ischemia    Reperfusion    Injury  :    may  contribute    to 
elaboration  of  NO  through    increased  expression  of  
iNOS.  and accompanying  Myocardial  depression that 
follows  successful  coronary  thrombolysis    or 
revascularization.   
In  Laennec’s   cirrhosis:  Increased  No  production 
owing  to  the  induction  of  NOS2  in  hepatocytes, 
Fibroblast and endothelia cell is believed to responsible 
for  the  hyperdynemic    circulatory  shock.  NO  Inhibit 
protein  synthesis  in  the  hepatocytes  at  post 
transnational  level  and  also  inhibit  several   
mitochondrial  enzyme  involved  in  electron  transport 
including Cis – aconitose. 
Inflammation:  No  enhances  the  effect  of 
cyclooxygenease and  stimulate the production of  Pro-
inflammators. No production can be induced through up 
gradation of  i NOS . by a number  of factor involved  
in  inflammation  e.g.  IL,  Interferon's,    gama,  TNF-
 
Excessive  amount  of  NO  impair  myline  production 
(Hall mark feature of  multiple sclerosis ) In Joint tissue 
it  result  in  acute  and  chronic    inflammation,   
characteristic sign of arthritis. 
Therapetic Use Of No : 
Use of Nitric is not totally new science inhaled amyl 
nitrite  was  used  to  treat  asthma  in  1866.  after  that 
Numerous studies have now confirmed the vasodilating 
effects  of  low-dose  nitrite  in  mice,  rats,  sheep,  dogs, 
primates and humans 
35-41. 
Use  of  NO  in  persistent  Pulmonary  HT  :  In  sheep 
models of PPHN, inhaled nitrite was converted to NO 
gas  in  the  lung  and  selectively  dilate  the  pulmonary 
circulation78. In such diseases, which are characterized 
by regional ischemia and vasoconstriction, nitrite may 
provide  an  ideal  stable  and  naturally  occurring 
therapeutic NO donor. NO is vasodilator of choice in 
term  babies  with  Persistent  Pulmonary  Hypertension.  
NO significantly improve Oxygenation. The therapeutic   
role of exogenously administered   nitric oxide is based 
on its direct vasodilator activity and extremely short life 
time. The inspired concentration of nitric Oxide may be 
monitored by chemilumescent detector. 
Clinically  useful  Bronchodilatation may be produced 
by inhaling   low concentration      ( 60 ppb  to  60pp ) 
for  selective    Pulmonary    vasodilatation    and 
improvement    in  oxygenation.  (Selectivity  for 
Pulmonary    circulation is due to the inhaled route of 
administration  and  its  rapid  deactivation      by 
hemoglobin in    pulmonary blood so that vasoactive 
concentration does not reach systemic circulation...)  
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Sindenafil  citrate  :  inhibits  production  of  
Phosphodiesterase enzyme    which  Break down  nitric 
oxide  . So this drug increase level of NO which relives  
smooth muscle in corpus cavernosa and increase blood  
flow into penis and make it erectile. Other vasodilator 
agents used are  
  Nitroglycerine  -  Use in angina pectoris 
  Sodium Nitropruside   - Hypertensive crisis 
  S-  nitriglutathions    -  inhibit    Platelet 
aggregation 
Tissue  protection  in  ischemia–reperfusion  injury.  : 
Systemic NOS-independent NO formation from nitrite 
was  first  demonstrated  in  the  ischemic  heart
6. 
Physiological  and  therapeutic  levels  of  nitrite  exert 
potent  cytoprotection  after  prolonged  ischaemia  and 
blood-flow  reperfusion  in  liver
12,42,  heart 
12,43,  brain
44 
and kidney
45. These findings suggest an opportunity for 
nitrite  therapy  for  human  diseases  associated  with 
ischaemia–reperfusion,  such  as  myocardial  infarction, 
stroke,  solid-organ  transplantation,  cardiopulmonary 
arrest and sickle-cell disease   
Dietary nitrate increased gastric NO levels and potently 
protected  against  the  macroscopic  injury  caused  by 
NSAID  exposure.  Nitrate  pretreatment  decreased 
mucosal  myeloperoxidase  activity  and  expression  of 
iNOS,  which  is  indicative  of  reduced  tissue 
inflammation.  The  protection  afforded  by  nitrate 
probably  relates  to  increased  gastric  mucosal  blood 
flow  and  mucusgeneration  and  reduced  epithelial 
permeability 
46,47.  An  additional  protective  effect  of 
nitrate  on  ulcer  development  may  occur  through 
inhibition of Helicobacter pylori
48. 
Topical  administration  of  acidified  inorganic  nitrite.: 
An  inorganic  nitrite  salt  such  as  sodium  nitrite 
(NaNO2)  is  combined  with  an  acidifying  agent  (for 
example, ascorbic acid). This mixture rapidly releases 
NO and  other nitrogen oxides and has been evaluated 
for  its  antimicrobial  activity.  Topical  application  of 
acidified  nitrite  to  the  skin  has  proved  effective  in 
various skin infections
49-51 
Role of NO in tumor cells
52 is by Direct and Indirect 
damage. It Directly damage to DNA by Inhibition of 
DNA   synthesis and inhibition of rate limiting Enzyme 
reboneucleotide    Reductase.  Reduced  activity  of  Cis 
aconitase  and  loss  of  large  fraction  of  the  iron  Pool, 
have also been suggested as possible mechanism. NO 
can  affect  mitochondria    leading  to  reduction  of 
consumption  and  damage  to  Complex  I  and  II  in 
mitochondrial electron transport chain, it also leads to 
reversible  inhibition of Complex IV and  induction of 
apoptosis. 
Low dose and short duration of treatment suggest that 
the risk of any carcinogenic effects is negligible. In fact 
as  stated  above,  a  large  consumption  of  nitrate-
containing  vegetables  may  provide  similar  or  even 
greater  systemic  loads  of  both  nitrate  and  nitrite.  If 
nitrite  is  to  be  used  in  much  higher  doses  over 
prolonged periods of time, this issue will naturally have 
to be addressed. 
USE OF NO BY OTHER  ANIMAL AND PLANTS 
Fire Fly's use NO to turn on their flashes. Plant also 
employ  NO  as  weapon  against   invading  pathogen. 
Infection  of  plant  triggers  the  formation  of  NOs  that 
like  the  animal  version  make  NO  from  arginine. 
Release of NO by the infected cell triggers number of 
defense   responses. 
 
FUTURE OF NO 
NOS gene. Therapy : Gene  therapy with NOs3 and use 
of long acting NO donor limit  vascular smooth muscle 
proliferation,  following    denuding    endothelia  injury, 
which suggest  potentially  useful  therapy for limiting  
re stenosis following  angioplasty 
(2)  Nitric oxide synthese is induced in the joints of 
patient  with  Rheumatoid  arthritis,  in  the    gut      of 
patient  with  ulcerative  colitis    and  the  ventricle  of 
patient with  cardiomyopathy. 
(3)  Exhaled  NO  is  a    novel  of  biometer    of 
respiratory   health in  epidemiological  studies. 
Future clinical studies will elucidate whether nitrate can 
offer  a  nutritional  approach  to  the  prevention  and 
treatment  of  disease.  If  such  investigations  point 
towards a protective effect of nitrate, the current strictly 
regulated levels of nitrate in food and drinking water 
may need to be reconsidered.  Thus, The discovery  of 
NO    as  an  essential    effectors    of  many  Biological  
phenomenon  surely stand out as one of most important 
achievement  of  20th    century  of  Biomedical 
investigation. 
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